Pandemic flu: will there be a second wave?
BMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b3394 (Published 20 August 2009) Cite this as: BMJ 2009;339:b3394All rapid responses
Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles or when it is brought to our attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not including references and author details. We will no longer post responses that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
Neam leaf is taken orally is very effective remedy for many viral
infections. Neem is a tree which ha smany antiviral properties and I feel
people shoudl try Neem leaf for Viral FLu.
Competing interests:
None declared
Competing interests: No competing interests
Sometimes simple truths can fall prey to expediency. If I think I
have
appendicitis, I would wish urgently to consult a surgeon. If I think I
may
have swine ‘flu, the diagnosis in the UK is now be based not on a medical
examination but on the National Pandemic telephone and internet Flu
Service, who offer diagnostic advice and commonly prescribe oseltamivir.
How can the profession and the public take seriously the many widely
circulated statistics of diagnosis, prevalence, morbidity or mortality of
any
non-specific symptom complex in patients seen by neither doctor nor
nurse? And on what basis do we permit the prescription of potentially
toxic
drugs by unqualified personnel? Is it possible to even speculate about
numbers of cases or second waves without a doctor's diagnosis.
What happened to our sense of duty and responsibility to the sick?
Under
the prevailing politically driven ‘management’ of the epidemic it is
impossible to make robust diagnoses, without which there can be no valid
data of clinical features, management, epidemiology or predictions.
Competing interests:
None declared
Competing interests: No competing interests
Dear Fiona Godlee,
Congratulations on your subdued tone on the rhetoric that swine ‘Flu
kills and Oseltomivir saves! (1) Epidemiology is an inexact science and
has never predicted the unpredictable future; neither can it do so in
future. It is some “sciencey” medical journalists who keep on harping on
this topic in the lay press supporting the manufacturers. They also
demonise all other methods of preventing or relieving ‘Flu symptoms. After
all Oseltomivir only shortens the symptoms by a whole long day. Beyond
that its usefulness is in doubt, especially in preventing or curing the
fatal complications.
By now we have enough evidence to show that Oseltomivir might not be
all that good and the dangerous adverse reactions could even be worse than
the disease. Japanese experience published in The Lancet in 2006, and the
present Oxford study published in your BMJ, along with the one in London
Times on line have all come to almost similar conclusions, although the
WHO, the governments, and the manufacturers keep refuting these scientific
claims for reasons best known to them. (2, 3)
Time was when small pox was thought to be due to the wrath of a
Goddess in the East. Time is now in the West to think of a virus as a
cause of all enigmatic problems like AIDS, SMON, ‘Flu of all shades down
the ages, ‘Flu like illnesses, viral fevers of all hues and colours, etc.
Even diseases like Beriberi and Pellagra were treated as infective
disorders for long periods of time. (4) God only knows how many innocent
humans were dispatched to meet their maker by that logic. Both, eastern
and western points of view are rational in that they have a cause and
effect relationship! Passion makes some of the best observations but draws
wretched conclusions many times.
However, human body defies that logic. If one goes deep into all the
deaths in the intensive therapy units due to ‘Flu, one is struck by the
glaring fact that it is the human immune system, for some unexplained
reason, getting overwhelmed in the setting. It is the cytokine aberrant
response that results in the final outcome of pneumonia and ARDS. Why does
the immune system do that is any body’s guess?
We need a holistic approach to the aetio-pathogenesis in that
setting, as in many other instances. Our skewed logic of a cause and
management might have to be recast sooner than later. Mary Tinnetti, of
Yale, in her milestone publication, The end of the disease era, points to
the lacunae and dangers of that approach. (5) She rightly points out that
in the present knowledge base that logic might result in under treatment
at best or over treatment, with more suffering for the patient, at worst.
‘Flu management needs such a holistic approach where the immune system
should get greater attention! Many complementary systems have that exact
approach. Let us explore the science behind those rather than condemning
them wholesale.
An analogy comes to mind. Before the 1980s sudden deaths at the
Moscow City Hospital used to be around thirty per day; all labelled as
myocardial infarctions. The epidemiologic statistic for Coronary disease
shot up until Maurice Lev and Saroja Bharati from California went over
there to perform detailed post mortem studies of those deaths with special
permission from Gorbochev. They revealed the cause, in most cases, as the
newly discovered alcoholic cardiomyopathy! (6) The latter was the main
culprit with an occasional sprinkling of myocardial infarcts. Gorbochev
banned Vodka in all Russian parties and rest is history!
Oseltomivir 75mg/24h PO has been provisionally recommended by NICE
for post- exposure prophylaxis in at-risk patients (i.e. immune-
compromised. Diabetics) avers the Oxford textbook of clinical medicine.
(books.google.co.in/books ISBN=0198570716.) But the media hype is that it
should be given as a prophylactic! The caption of this letter is
attributed to Benjamin Disraeli but was popularized in the USA by Mark
Twain.
The next point that is raised in your editorial is the future
prediction of a winter avalanche of swine ‘flu in the Northern hemisphere.
Much of the ‘Flu scare in the Southern hemisphere today also is based on
media hype, thanks to the electronic media’s power to sell any idea with
its 24/7 visibility! Our estimated guess for the future, like that of an
astrologer’s predictions, will certainly fall short of expectations.
History will record our botched attempt at making a mountain out of a mole
hill of the last Bird ‘Flu scare where scientific scrutiny (changing anti
bird ‘flu antibody titre based diagnosis) did not show any confirmed human
deaths.
Less said about the vaccine, threatening to be let loose on the
gullible public, the better in view of the enormous capacity of the virus
to mutate faster than a chameleon changing its colours. This should not
belittle the dangerous role played by the preservatives in the vaccine.
Modern medicine is not based on hard science. It is only statistical
science of ranodmised studies and short term cross sectional cohort
studies. We need better scientific basis for medicine as shown by David
Eddy (7) and Douglas C Wallace (8) in their epochal studies, not to
mention many other attempts by true scientists to change the face of
modern medicine and make it more scientific in view of the new revelations
in quantum mechanics which has shown the significance of human
consciousness. (9, 10, 11)
Mind rules the body. Fear affects the immune system adversely. Let us
do all we have to do in this time of stress but not let the lay people be
frightened to death due to sheer fear of ‘Flu. Scare mongering is a good
business proposition but bad medical ethics. Let us not make a mockery of
our efforts to be called medical scare system while our aim is to “comfort
mostly and console always”. “Cure” we do rarely! Let us remind ourselves
of what T. S. Eliot wrote: “where is the wisdom we seem to have lost in
knowledge, and where is that knowledge that we have lost in information?”
How true in relation to this ‘Flu outbreak? Medical world is deluded with
information most of it being “noise”. The occasional “signal” in the noise
is lost in the bargain!
Yours ever,
Bmhegde
References:
1) Godlee F. Pandemic ‘Flu: will there be a second wave? BMJ 2009; 339:
b3394.
2) Jefferson T, Demichelli V, Rivetti R et. al. Antivirals for influenza
in healthy adults. Lancet 2006; 367: 303-315.
3) The Times, London July 31, 2009.
4) Duesberg P. Inventing the AIDS virus. 2004. Regnery Publishers, USA.
5) Tinnetti M, Stead T. The end of disease era. Am J Med. 2004; 116: 179-
183.
6) Lev M and Bharati S. Cardiac conduction system in unexplained sudden
death. Ann. Int. Med. 1991; 115: 834.
7) Smith R. Where is the wisdom? BMJ 1991; 303: 798-799.
8) Wallace DC. Mitochondria as Chi. Genetics 2008; 179: 727-785.
9) Hegde BM. Reductionism to holism-the flip-flop science of modern
medicine. JSHO 2008; 1: 05.
10) Smith R. Illness to wellness: Pursuing health and fleeing disease.
JSHO 2009; 1: 07.
11) Chopra D, Weil A, Roy R. Leave the sinking ship. JSHO 2009; 1: 11-12.
Competing interests:
None declared
Competing interests: No competing interests
Roche letter of response to: Pandemic flu: will there be a second wave?
Dear Dr Godlee
There has been much debate over the past few months over the use of
Tamiflu®(oseltamivir) in children and additionally the potential for
resistance to develop as a result of widespread usage.1
At present, antiviral therapies are currently the only available
therapeutic option to prevent and treat infection with the pandemic (H1N1)
2009 virus. The Tamiflu Summary of Product Characteristics (SPC) indicates
the medicine to be effective and well tolerated when used for the
treatment or prevention of influenza in children.2 Whilst new research on
the use of Tamiflu in children is welcomed, the study by Shun-Shin and
colleagues3 should not be viewed in isolation.
The European Medicines Agency has reviewed the data from controlled
clinical trials and approved oseltamivir to treat and prevent influenza in
those aged one year and over based upon a positive benefit/risk
assessment.2 Data contained in the SPC show that in otherwise healthy
children (under 12s) who had fever plus either cough or coryza,
oseltamivir treatment, started within 48 hours of onset of symptoms
significantly reduces the time to alleviation of illness by 1.5 days
compared to placebo. Tamiflu reduced the incidence of acute otitis media
from 26.5 % in the placebo group to 16 % in the oseltamivir treated
children.2 In a group of asthmatic children, the median duration of
illness was not reduced significantly in those treated with oseltamivir,
although by day 6 of treatment, respiratory function (Forced Expiratory
Volume) had increased by 10.8 % in the oseltamivir treated group compared
to 4.7 % on placebo in this group.2
It is essential for medical experts to continue to closely scrutinise
this emergent pandemic strain to ensure the balance between benefit and
risk is appropriate for the threat to children who contract the disease.
With regards to resistance, ongoing testing shows that currently
circulating pandemic virus remains susceptible to Tamiflu.4-7 Roche takes
the issue of resistance seriously and is working as a collaborative and
responsible partner to monitor the situation. Roche is in contact with
established surveillance groups from around the world to review influenza
A (H1N1) resistance. At present there have been just 13 isolated cases in
which the virus has been resistant to Tamiflu,8 which should be viewed in
the context more than 2,000 virus isolates from 119 countries and 180
clinical specimens evaluated from the USA, which have been tested for
resistance.9
Sincerely,
Dr Michelle Rashford
Medical Director
Roche Products Limited
References
1. Godlee F. Pandemic flu: will there be a second wave? BMJ
2009;339:b3394
2. Tamiflu Summary of Product Characteristics.
http://emc.medicines.org.uk/ (accessed August 2009)
3. Shun-Shin M, Thompson M, Heneghan et al. Neuraminidase inhibitors for
treatment and prophylaxis of influenza in children: systematic review and
meta-analysis of randomised controlled trials. BMJ 2009 339: b3172
4. World Health Organization. Swine Influenza Frequently Asked Questions.
http://www.who.int/csr/disease/swineflu/frequently_asked_questions/swine...
5. Health Protection Agency. Weekly Pandemic Flu Media Update.13 August
2009 (Week 33)
6. Interim Guidance on Antiviral Recommendations for Patients with Novel
Influenza A (H1N1) Virus Infection and Their Close Contacts. Centers for
Disease Control. May 2009
7. Itoh Y, Shinya K, Kiso M, et al. In vitro and in vivo characterization
of new swine-origin H1N1 influenza viruses. Nature (Letters)
doi:10.1038/nature08260
8. Roche: Data on file.
9. World Health Organization. Weekly epidemiological record. 4 September
2009 http://www.who.int/wer/2009/wer8436/en/index.html
Competing interests:
Manufacturer of Tamiflu
Competing interests: No competing interests